Ergoteles LLC Haemonetics Corp Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $940,492 - $1.04 Million	11,634 New	11,634 $990,000
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $158,999 - $185,459	2,153 Added 21.47%	12,180 $957,000
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $634,709 - $788,723	10,027 New	10,027 $742,000
Q1 2021 May 12, 2021	SELL	$111.01 - $139.48 $222,020 - $278,960	-2,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$88.75 - $119.95 $177,500 - $239,900	2,000 New	2,000 $238,000

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.